stockrow
Friday 6 November 2026
Export HCTI’s income statement to Excel — free account
Healthcare Triangle, Inc.
HCTI Healthcare Health Information Services
Healthcare Triangle, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.9 million, up 18.8% from fiscal 2024.
- Revenue
- +158.4%
- EPS
- +95.5%
- Free cash flow
- +67.5%
- Total debt
- +2,749.9%
Quarter to June 2026, against a year earlier
3.66
0.07
+1.95%
Follow HCTI
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 2 | 4 | 3 |
+8 more TTM periods Free account |
| (128.77%) | (98.39%) | 188.76% | 2,398.86% | ||
| (38.60%) | (30.40%) | (76.74%) | (67.95%) | ||
ROIC |
(15.59%) | (12.92%) | (46.86%) | (42.32%) | |
Return on Tangible Assets |
330.40% | 1,819.53% | (2,603.30%) | (156.65%) | |
Average Days of Receivables |
87.93 | 152.38 | 54.39 | 68.85 | |
Free Cash Flow per Share |
(125.27) | (383.22) | (5,816.77) | (3,188.92) | |
Free Cash Flow |
(17.58) | (17.86) | (18.03) | (11.80) | |
Capital Expenditures |
(1.55) | (0.03) | (1.51) | (1.30) | |
| Other line items | |||||
Cash ROIC |
(27.97%) | (26.76%) | (63.70%) | (99.28%) | |
Accounts Receivable Turnover |
6.38 | 3.90 | 8.74 | 6.39 | |
Accounts Payable Turnover |
12.31 | 6.56 | 7.31 | 6.24 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
21.72 | 74.60 | 22.63 | 42.46 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1.84% | 2.38% | 3.86% | 1.38% | |
Selling, General and Administrative Expense of Revenue |
68.50% | 69.08% | 75.02% | 59.18% | |
Share Based Compensation of Revenue |
1.62% | 0.00% | 3.25% | 3.34% | |
Interest Coverage |
(47.97) | (50.27) | (17.26) | (4.43) | |
Operating CF/Net income |
0.94 | 1.28 | 1.74 | 1.66 | |
Depreciation/Fixed assets |
1.70 | 1.13 | 185.60 | 183.00 | |
Capex/Depreciation |
(0.76) | (0.02) | (1.63) | (1.42) | |
Revenue per Share |
183.02 | 430.09 | 4,480.97 | 3,497.57 | |
Operating CF per Share |
(114.24) | (382.62) | (5,330.00) | (2,837.84) | |
Capex per Share |
(11.03) | (0.60) | (486.77) | (351.08) | |
Capex to Sales |
0.06 | 0.00 | 0.11 | 0.10 |
Columns are period end dates · fundamentals updated 2 Nov 2026